Effects of Maternal Diabetes and Diet on Gene Expression in the Murine Placenta

Abstract

Adverse exposures during pregnancy have been shown to contribute to susceptibility for chronic diseases in offspring. Maternal diabetes during pregnancy is associated with higher risk of pregnancy complications, structural birth defects, and cardiometabolic health impairments later in life. We showed previously in a mouse model that the placenta is smaller in diabetic pregnancies, with reduced size of the junctional zone and labyrinth. In addition, cell migration is impaired, resulting in ectopic accumulation of spongiotrophoblasts within the labyrinth. The present study had the goal to identify the mechanisms underlying the growth defects and trophoblast migration abnormalities. Based upon gene expression assays of 47 candidate genes, we were able to attribute the reduced growth of diabetic placenta to alterations in the Insulin growth factor and Serotonin signaling pathways, and provide evidence for Prostaglandin signaling deficiencies as the possible cause for abnormal trophoblast migration. Furthermore, our results reinforce the notion that the exposure to maternal diabetes has particularly pronounced effects on gene expression at midgestation time points. An implication of these findings is that mechanisms underlying developmental programming act early in pregnancy, during placenta morphogenesis, and before the conceptus switches from histiotrophic to hemotrophic nutrition.

Gut-derived peptide hormone receptor expression in the developing mouse hypothalamus

“…Plasma CCK levels are reported to increase during pregnancy [ 64 ]. Interestingly, CCK and its receptor expression have been detected in both human and mouse placentas [ 65 ] and differential expression in the placenta of diabetic mothers has been found [ 66 ]. In the ARH, CCK expression was decreased during the course of lactation in rats [ 25 ], which could explain the hyperphagia accompanying this period.…”